Related Experiment Videos
[Various parameters of hemostasis in patients with chronic liver diseases]
Insights
This study found that patients with chronic liver disease often have abnormal platelet function and clotting factors. Enhanced serotonin levels in platelets were observed in cirrhosis and chronic active hepatitis patients.
Area of Science:
- Hematology
- Hepatology
- Biochemistry
Context:
- Chronic liver disease (CLD) affects multiple organ systems, including hemostasis.
- Platelet dysfunction is a known complication of advanced liver disease.
- Understanding these hemostatic changes is crucial for managing CLD patients.
Purpose:
- To investigate platelet function and hemostatic/fibrinolytic activity in CLD patients.
- To explore correlations between platelet abnormalities and coagulation/fibrinolysis.
- To identify specific markers associated with different CLD types.
Summary:
- Patients with biopsy-proven CLD (n=33) showed mild decreases in prothrombin activity, antithrombin III (AT III), and plasminogen.
- Significantly elevated intraplatelet serotonin (5HT) levels were found in patients with cirrhosis and chronic active hepatitis.
- Correlations between parameters were generally absent, except for prothrombin activity and AT III levels in cirrhotic patients.
Impact:
- Provides insights into the complex hemostatic profile of CLD patients.
- Highlights the potential role of intraplatelet serotonin in liver disease pathophysiology.
- May inform future diagnostic or therapeutic strategies targeting coagulation and platelet function in CLD.
Abstract:
The aim of the study was to investigate the nature and the possible correlations between abnormalities of platelet function and haemostatic and fibrinolytic activity in a group of 33 patients with biopsy-proven chronic liver disease. A slight decrease in prothrombin activity, AT III and plasminogen levels was noticed in the patients studied. Significantly enhanced levels of intraplatelet 5HT was also found in patients with cirrhosis and in those with chronic active hepatitis. Changes in these parameters were generally independent from each other, the only correlation being found between prothrombin activity and AT III levels in patients with cirrhosis.